Charts Actuate Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 01:30:00 19/09/2026 am IST			5-day change	1st Jan Change
0.9812 ^USD	-1.41%		-8.30%	-83.97%

09/09	Actuate Therapeutics Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with Ras Inhibitors Zoldonrasib and Daraxonrasib	CI
15/08	Actuate Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

NasdaqUSD

Markets		Quality
Nasdaq	ACTU	Delayed
CBOE	ACTU	Real-time

ProRealTime Chart